Abbott Laboratories (ABT) stock rallied over 0.73% intraday to trade at $106.21 a share on NYSE. The stock opened with a gain of 2.57% at $105.95 and touched an intraday high of $106.78, rising 0.73% against the last close of $105.44. The stock went to a low of $105.07 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue44.51 Billion
5Y Sales Change15.60%
Fiscal Year Ends2021-12-30
IndustryHealth Care Equipment
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Meniere's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Abbott Laboratories (NYSE: ABT) stock price is $106.21 as of the last check on Thursday, June 23. During the trading session, ABT stock reached the peak price of $106.78 while $105.07 was the lowest point it dropped to.
The NYSE listed ABT is part of Health Care Equipment industry that operates in the broader Health Care sector. Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
Mr. Robert B. Ford
Chairman, Pres & CEO
Mr. Robert E. Funck Jr.
Exec. VP of Fin. & CFO
Mr. Hubert L. Allen
Exec. VP, Gen. Counsel & Sec.
Mr. Daniel Gesua Sive Salvadori
Exec. VP and Group Pres of Established Pharmaceuticals & Nutritional Products
ABT stock traded closed the last session at $106.21, which is $0.77 or 0.73% lower than its previous close of $105.44. ABT's current trading price is 4.91% lower than its 52-week high of $142.60 where as its distance from 52-week low of 101.24% is -25.52%.
Number of ABT employees currently stands at -. ABT operates from 100 Abbott Park Road, Abbott Park, North Chicago, IL 60064-6400, United States.
Official Webiste of $ABT is: https://www.abbott.com
ABT stock volume for the day was 5,059,583 shares while in the previous session number of ABT shares traded was 5,064,800 . The average number of ABT shares traded daily for last 3 months was 5.33 Million.
The percentage change in ABT stock occurred in the recent session was 0.73% while the dollar amount for the price change in ABT stock was $0.77.
In the recent session, the day high for ABT stock was $106.78 while the low for ABT stock touched on the day was $105.07.
The market value of ABT currently stands at 185.13 Billion with its latest stock price at $106.21 and 1.76 Billion of its shares outstanding.